glp 1 agonist ilaçlar GLP-1 AGONİSTLERİ! #glp1 #glp #sağlık #diyetisyen #diyetisyentavsiyesi #beslenme #zayıflama #zübeydesemiz Kilo Verdiren İlaçlar: GLP-1 Agonistleri
Description
A study in July 2024 by researchers at Mass Eye and Ear in Boston found that people taking semaglutide for type 2 diabetes or weight loss had a higher risk of developing nonarteritic anterior ischemic optic neuropathy, an eye condition that can cause blindness, than people taking medications other than GLP-1 drugs for diabetes or obesity
Found Health makes this distinction clear in its terms of use, and understanding it matters
doi:10.1007/s00404-024-07849-9 Ivanisevic M, Herman M, Horvaticek M, Vucic Lovrencic M, Delmis J
High-frequency oscillations in circulating amylin concentrations in healthy humans
They add that any weight loss medication regimen should be used in conjunction with a healthy diet and regular exercise
